Searched over 200M research papers
10 papers analyzed
These studies suggest that blood pressure and heart rate are interrelated, influenced by genetic and environmental factors, and central nervous mechanisms, with heart rate variability being crucial for cardiovascular health assessment.
20 papers analyzed
Research has shown that blood pressure undergoes significant changes throughout pregnancy. A systematic review and meta-analysis of 39 studies involving over 36,000 women revealed that systolic blood pressure (SBP) is lowest at around 10 weeks of gestation, averaging 110.4 mmHg, and increases to 116.0 mmHg by 40 weeks. Similarly, diastolic blood pressure (DBP) is lowest at 21 weeks, averaging 65.9 mmHg, and rises to 72.8 mmHg by 40 weeks. These findings challenge the commonly taught notion of substantial mid-pregnancy decreases in blood pressure.
The same study also found that heart rate increases during pregnancy, from an average of 79.3 beats per minute (bpm) at 10 weeks to 86.9 bpm at 40 weeks. This increase is lower than previously thought, suggesting that heart rate changes during pregnancy may need to be reassessed in clinical practice.
Heart rate variability (HRV) is a measure of the variation in time between each heartbeat, and it is an important indicator of cardiovascular health. High HRV is generally a sign of good cardiovascular function, while low HRV can indicate stress or potential heart problems. HRV can be analyzed using time-domain and frequency-domain methods, which provide insights into autonomic regulation and cardiovascular health.
Studies have shown that both normotensive and hypertensive individuals exhibit significant variability in blood pressure and heart rate over 24-hour periods. However, hypertensive individuals tend to have greater absolute variabilities in blood pressure compared to normotensive individuals, although their heart rate variabilities are similar. This suggests that while blood pressure variability is more pronounced in hypertensives, heart rate variability remains consistent across different blood pressure conditions.
Genetic factors play a significant role in determining blood pressure and heart rate. A systematic review of twin studies found that the heritability of systolic and diastolic blood pressure is around 50%, indicating a substantial genetic contribution. The heritability of heart rate and pulse pressure also shows significant genetic influence, although fewer studies have been conducted on these phenotypes.
Increased heart rate has been identified as a predictor of sustained hypertension and is associated with higher risks of cardiovascular and non-cardiovascular mortality. Despite this, heart rate is often overlooked in clinical practice when assessing cardiovascular risk.
Data from the World Health Organization-Cardiovascular Disease and Alimentary Comparison (CARDIAC) study indicate that increased resting heart rates are significantly correlated with higher systolic and diastolic blood pressure. This relationship supports the hypothesis that elevated heart rates may contribute to cardiovascular mortality through increased blood pressure.
While elevated heart rate is associated with increased blood pressure and cardiovascular risk, it is not typically a major consideration in choosing antihypertensive medications. This is partly due to the lack of evidence supporting heart rate lowering as a therapeutic strategy in hypertension. Additionally, there is a complex relationship between heart rate and central versus peripheral blood pressure, which complicates the use of heart rate-lowering medications.
Recent research highlights the dynamic nature of blood pressure and heart rate, particularly during pregnancy and in the context of cardiovascular health. Understanding these changes and their genetic underpinnings can improve the assessment and management of cardiovascular risk. However, more research is needed to fully integrate heart rate considerations into hypertension treatment strategies.
Most relevant research papers on this topic